HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GNC Fills Executive Suite For ‘Consumer-Centric’ Approach Under Harbin’s Ownership

Executive Summary

GNC appoints Nate Frazier COO and Karlyn Mattson CMO as it continues to build leadership team and instill “consumer-centric” omni-channel approach under owner Harbin Pharmaceutical.

You may also be interested in...



GNC Distributes Supplements To 645 Truck Stops, Stocks BetterLungs In Its Stores

Betterbrand’s pharmacist-formulated supplements with a focus on upper respiratory and lung health are available at select GNC stores. GNC offers five on-the-go essentials at participating locations coast-to-coast of Pilot Flying J travel centers.

HBW US Executive Decisions: CRN Communications Director, GNC Science And People Chiefs

Aker BioMarine provides krill oil for e-sports team Heroic to reach market with “massive growth in recent years”; award-winning public relations strategist Craig Muckle joins CRN; and GNC names chief science and chief people officers. 

GNC’s Sale Attracts No Competitors For Harbin’s Bid; Chapter 11 Bankruptcy Auction Cancelled

Deadline passed for “other qualified bidders to submit higher or otherwise better offers to purchase” full ownership of GNC. Approving sale to Harbin Pharmaceuticals, already its largest shareholder, depends partly on approval by US bankruptcy court, where a hearing is set for 17 September.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151589

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel